Literature DB >> 28051029

A POU3F4 Mutation Causes Nonsyndromic Hearing Loss in a Chinese X-linked Recessive Family.

Wan Du1, Ming-Kun Han1, Da-Yong Wang1, Bing Han1, Liang Zong1, Lan Lan1, Ju Yang1, Qi Shen1, Lin-Yi Xie1, Lan Yu1, Jing Guan1, Qiu-Ju Wang1.   

Abstract

BACKGROUND: The molecular genetic research showed the association between X-linked hearing loss and mutations in POU3F4. This research aimed to identify a POU3F4 mutation in a nonsyndromic X-linked recessive hearing loss family.
METHODS: A series of clinical evaluations including medical history, otologic examinations, family history, audiologic testing, and a high-resolution computed tomography scan were performed for each patient. Bidirectional sequencing was carried out for all polymerase chain reaction products of the samples. Moreover, 834 controls with normal hearing were also tested.
RESULTS: The pedigree showed X-linkage recessive inheritance pattern, and pathogenic mutation (c.499C>T) was identified in the proband and his family member, which led to a premature termination prior to the entire POU domains. This mutation co-segregated with hearing loss in this family. No mutation of POU3F4 gene was found in 834 controls.
CONCLUSIONS: A nonsense mutation is identified in a family displaying the pedigree consistent with X-linked recessive pattern in POU3F4 gene. In addition, we may provide molecular diagnosis and genetic counseling for this family.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28051029      PMCID: PMC5221118          DOI: 10.4103/0366-6999.196565

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


Introduction

Hearing loss is one of the common sensory disorders in humans, affecting 1 in 1000 newborns. More than one half of it may attribute to genetic factors. Among them, it showed that hearing loss is transmitted with a heredity form concurrent with autosomal recessive (75%), dominant (20%), X-linked (3%), and others (2%). So far, five loci (DFNX1, DFNX2, DFNX3, DFNX4, and DFNX6) and four genes (PRPS1, POU3F4, SMPX, and COL4A6) have been found for X-linked hearing impairment.[1] The clinical features of DFNX3 comprise profound mixed hearing loss and vestibular problems in males.[2] The molecular genetic research showed the association between X-linked hearing loss and mutations in POU3F4.[3] This gene belongs to a superfamily of POU domain transcription factors (transcription factor 4 of the POU domain, Class III), which encodes transcription factor with bipartite DNA-binding domains, a 75-amino acid POU-specific domain that is linked by 17 amino acids to a 63-amino acid homeobox domain. Both subdomains contain helix-turn-helix motifs that directly associate with the two components of bipartite DNA-binding sites. Animal models also showed that the expression of Brn-4 (POU3F4 synonyms) was highly associated with remodeling of the otic capsule.[4] There are 52 variants reported in the Human Gene Mutation Database, including intragenic mutations, complete or partial deletions, duplications, inversions, and other chromosomal deletions.[5] To identify the mutation in the POU3F4 gene, in this study, we performed the analysis in a Chinese nonsyndromic X-linked hereditary hearing loss family.

Methods

Clinical evaluation

The proband, a 10-year-old boy, presented to the otolaryngology clinic with genetic severe deafness and speech delay. His family history was obtained by his mother. He was subjected to detailed clinical evaluations including medical history, family history, otologic examinations, audiologic testing (pure-tone audiometry, tympanometry, acoustic reflex, auditory brainstem response, and 40 Hz auditory events-related potential), and high-resolution axial computed tomography (CT) scan of temporal bones. This research was approved by the collectors’ Institutional Review Board of the Ethics Committee at Chinese People's Liberation Army General Hospital.

Molecular genetic analysis

After getting informed consent from all participants and parents of persons <18 years, genomic DNA was extracted from peripheral blood leukocytes of the proband (V1) and other members of family (IV1, IV2, IV3, IV4, IV5, IV6, III1) using standard procedures. Moreover, 834 controls with normal hearing were also tested. The coding region of POU3F4 was amplified by polymerase chain reaction (PCR) with two pairs of primers. The first pair primers were a forward primer (5′-TAACCCGTGCTAGCGTCTTT-3′) and a reverse primer (5′-GAACCTGCAGATGGTGGTCT-3′) and the second pair primers were a forward primer (5′-CAACCTCTGATGAGTTGGAACA-3′) and a reverse primer (5′-AAAGGAAGAGATGGAAGGGAAG-3′). The PCR procedure was as follows: 95°C for 5 min, followed by 32 cycles of denaturation at 94°C for 45 s; annealing at 56°C for 30 s, extension at 72°C for 30 s, and a final elongation at 72°C for 7 min. All the PCR products were purified and subjected to sequencing in both directions using a DNA sequencer (ABI 3730).

Results

Clinical investigations

The five-generation pedigree presented with an X-linkage recessive inheritance pattern of hearing loss. Otomicroscopical examination showed intact tympanic membranes and no middle ear effusion in proband (V1). Moreover, pure tone audiometry indicated bilateral severe to profound deafness, but bone hearing thresholds were normal at 250 Hz. Further, high-resolution axial CT scan revealed a dilatation of the lateral end of the internal auditory meatus and a deficit or absence in the basal turn of the cochlea [Figure 1].
Figure 1

The clinical features and genetic testing results of the proband and the family member. (a) Pedigree of the family. The incidence pattern of the pedigree shows X-linked hereditary; (b) The imaging tests of the proband. The high-resolution axial computed tomography reveals a dilatation of lateral end of the internal auditory meatus and a deficit or absence in the basal turn of the cochlea; (c) Audiograms of the proband. The pure tone audiometry shows belated severe to profound hearing loss, but bone hearing thresholds was normal (10 dB) at 250 Hz; (d) Sequencing chromatograms of POU3F4. The molecular testing result of proband and so family members.

The clinical features and genetic testing results of the proband and the family member. (a) Pedigree of the family. The incidence pattern of the pedigree shows X-linked hereditary; (b) The imaging tests of the proband. The high-resolution axial computed tomography reveals a dilatation of lateral end of the internal auditory meatus and a deficit or absence in the basal turn of the cochlea; (c) Audiograms of the proband. The pure tone audiometry shows belated severe to profound hearing loss, but bone hearing thresholds was normal (10 dB) at 250 Hz; (d) Sequencing chromatograms of POU3F4. The molecular testing result of proband and so family members.

Identification of the mutation in POU3F4 gene

Variant analysis of the POU3F4 was performed for the radiologic results. Sequence screening of all the family members showed a nonsense mutation at nucleotide position c.499C>T in the proband (V1) and his uncle with hearing loss phenotype (IV3). The proband's mother (IV1), one aunt (IV2), and grandmother (III1) carried the c.499C>T mutation without hearing loss phenotype. The proband's other two aunts (IV4, IV5) and another uncle (IV6) showed normal hearing without any mutation. No mutation of POU3F4 gene was found in 834 controls. The location of POU3F4 gene on the X chromosome and the variations found on this gene were shown in Figure 2.
Figure 2

The location of POU3F4 gene on the X chromosome and the variations found on this gene.

The location of POU3F4 gene on the X chromosome and the variations found on this gene.

Discussion

In recent years, studies have performed on POU3F4 gene mutations in different countries. Until now, mutations in this gene have been identified containing missense mutations, in-frame deletions, and truncating mutations [Table 1].
Table 1

The genotype distribution of POU3F4 gene mutations

YearNucleotideProteinAuthorsReference
1988c.715C>Tp.S228LBrunner et al.[6]
1995c.604A>Tp.K202XDe Kok et al.[3]
1995c.607_610del4De Kok et al.[3]
1995c.648del1De Kok et al.[3]
1995c.862_865del4Bitner-Glindzicz et al.[7]
1995c.896del1De Kok et al.[3]
1995c.935C>Tp.A312VBitner-Glindzicz et al.[7]
1995c.950T>Gp.L317WDe Kok et al.[3]
1995c.1000A>Gp.K334EDe Kok et al.[3]
1997c.689C>Tp.T230IFriedman et al.[8]
1997c.985C>Gp.R329GFriedman et al.[8]
1997c.990A>Tp.R330SDe Kok et al.[9]
1998c.601_606del6Hagiwara et al.[10]
2000c.200G>Ap.W67XCremers et al.[11]
2000c.907C>Tp.P303SCremers et al.[11]
2000c.967C>Gp.R323GCremers et al.[11]
2000c.983A>Cp.N328TCremers et al.[11]
2005c.683C>Tp.S228LVore et al.[12]
2006c.925T>Cp.S309PWang et al.[13]
2009c.293C>Ap.S98XMarlin et al.[14]
2009c.346del1Lee et al.[15]
2009c.383del1Lee et al.[16]
2009c.623T>Ap.L208XLee et al.[16]
2009c.923T>Ap.I308NMarlin et al.[14]
2009c.927_929del3Lee et al.[15]
2009c.986G>Cp.R329PLee et al.[15]
2010c.499C>Tp.R167XStankovic et al.[17]
2010c.647G>Ap.G216ELi et al.[18]
2011c.341G>Ap.W114Waryah et al.[19]
2011c.406C>Tp.Q136Waryah et al.[19]
2011c.973T>Ap.W325RSchild et al.[20]
2013c.235C>Tp.Q79XParzefall et al.[21]
2013c.632C>Tp.T211MChoi et al.[22]
2013c.686A>Gp.Q229RChoi et al.[22]
2013c.853_854delATParzefall et al.[21]
2013c.950dupTChoi et al.[22]
2013c.1060delAChoi et al.[22]
2013c.1084T>Cp.X362RChoi et al.[22]
The genotype distribution of POU3F4 gene mutations This is the first study to identify a nonsense mutation c.499C>T in POU3F4 gene in Asians. So far, the most identified mutations of POU3F4 gene are located in nucleotide poison-encoding POU domain.[45918] The c.499C>T mutation changes an arginine (CGA) to a stop code (ATG), which leads to a premature termination prior to the entire POU domains in amino acid level.[17] This mutation co-segregates with hearing loss in this family. Male members carried c.499C>T mutation. However, females with this mutation are normal hearing. Therefore, we consider that this mutation may be the cause of disease etiology of the pedigree. By molecular testing, we provided definitive diagnosis and genetic counseling for this family and further enriched pathogenic mutation spectrum of POU3F4 gene. Pedigree analysis is an important approach to search the underlying cause of hearing loss. However, more patients with hearing loss were sporadic and there is a lack of characteristic phenotype in clinical practice. Hence, using all the available phenotypic clues to direct molecular testing would be cost-effective. The clinical features of CT images of the temporal bones are now well recognized through reported cases.[11212324] Besides the characteristics of CT images, audiological phenotype of DFNX3 is defined as profound deafness with or without a conductive element.[7141925] The conductive component in the audiogram could also be concerned about because of an atypical communication between an internal auditory canal and the inner ear leading to a pathologic third window which deteriorates air-conducted thresholds and increases bone-conducted thresholds. The supposed improvement in bone conduction sensitivity could be concealed by a true sensorineural deafness following the disorder.[1526] The proband had a profound deafness but displayed normal bone conductive hearing at 250 Hz. Based on other authors’ records and our experience, it was revealed that patients with this type of audiogram of low-frequency air–bone gap increased suspicion for inner malformation. Subsequent axial CT images of the temporal bones showed the defects of the bony labyrinth in proband such as a symmetric bulbous dilatation of the internal auditory canals in both ears and partial separation of the cochlea with the fundus of internal auditory canals, which was consistent with DFNX3. It was the above clinical information that guided us to reveal the causative mutation of this family. Last but not the least, DFNX3 has already been diagnosed in molecular level, so POU3F4 gene should be screened in the outpatient persons who have the clinical phenotypes of DFNX3.[272829] Our study also has some limitations. On one hand, more pedigree and sporadic people should be recruited. On the other hand, new and rapid technique should be adopted to detect the patients. In conclusion, a nonsense mutation is identified in a Chinese family displaying the pedigree consistent with X-linked recessive pattern in POU3F4 gene. Furthermore, we may provide molecular diagnosis and genetic counseling for this family.

Financial support and sponsorship

This work was supported by the grants from the National Key Basic Research Program of China (No.2014CB943001), the National Natural Science Foundation of China (No. 81120108009 and No. 81530032), and the China Postdoctoral Science Foundation (No.2015M572690).

Conflicts of interest

There are no conflicts of interest.
  27 in total

1.  X-linked deafness, stapes gushers and a distinctive defect of the inner ear.

Authors:  P D Phelps; W Reardon; M Pembrey; S Bellman; L Luxom
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  The gene for X-linked progressive mixed deafness with perilymphatic gusher during stapes surgery (DFN3) is linked to PGK.

Authors:  H G Brunner; A van Bennekom; E M Lambermon; T L Oei; W R Cremers; B Wieringa; H H Ropers
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

3.  Identification of a novel mutation in POU3F4 for prenatal diagnosis in a Chinese family with X-linked nonsyndromic hearing loss.

Authors:  Jianzhong Li; Jing Cheng; Yanping Lu; Yu Lu; Aiting Chen; Yi Sun; Dongyang Kang; Xin Zhang; Pu Dai; Dongyi Han; Huijun Yuan
Journal:  J Genet Genomics       Date:  2010-12       Impact factor: 4.275

4.  Novel mutation in the homeobox domain of transcription factor POU3F4 associated with profound sensorineural hearing loss.

Authors:  Christian Schild; Erick Prera; Nicola Lüblinghoff; Susan Arndt; Antje Aschendorff; Ralf Birkenhäger
Journal:  Otol Neurotol       Date:  2011-06       Impact factor: 2.311

5.  Computed tomographic diagnosis of X-linked congenital mixed deafness, fixation of the stapedial footplate, and perilymphatic gusher.

Authors:  J M Talbot; D F Wilson
Journal:  Am J Otol       Date:  1994-03

6.  HRCT and MRI findings in X-linked non-syndromic deafness patients with a POU3F4 mutation.

Authors:  Wu-Xian Gong; Ruo-Zhen Gong; Bin Zhao
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2014-08-17       Impact factor: 1.675

7.  Cytoplasmic mislocalization of POU3F4 due to novel mutations leads to deafness in humans and mice.

Authors:  Thomas Parzefall; Shaked Shivatzki; Danielle R Lenz; Birgit Rathkolb; Kathy Ushakov; Daphne Karfunkel; Yisgav Shapira; Michael Wolf; Manuela Mohr; Eckhard Wolf; Sibylle Sabrautzki; Martin Hrabé de Angelis; Moshe Frydman; Zippora Brownstein; Karen B Avraham
Journal:  Hum Mutat       Date:  2013-05-08       Impact factor: 4.878

8.  Air-bone gap in patients with X-linked stapes gusher syndrome.

Authors:  A F Snik; G C Hombergen; E A Mylanus; C W Cremers
Journal:  Am J Otol       Date:  1995-03

9.  A new mutation in the POU3F4 gene in a Japanese family with X-linked mixed deafness (DFN3).

Authors:  H Hagiwara; Y Tamagawa; K Kitamura; K Kodera
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

10.  Novel domain-specific POU3F4 mutations are associated with X-linked deafness: examples from different populations.

Authors:  Guney Bademci; Akeem Lasisi; Kemal O Yariz; Paola Montenegro; Ibis Menendez; Rodrigo Vinueza; Rosario Paredes; Germania Moreta; Asli Subasioglu; Susan Blanton; Suat Fitoz; Armagan Incesulu; Levent Sennaroglu; Mustafa Tekin
Journal:  BMC Med Genet       Date:  2015-02-25       Impact factor: 2.103

View more
  7 in total

1.  A novel mutation in the SMPX gene associated with X-linked nonsyndromic sensorineural hearing loss in a Chinese family.

Authors:  Yuyuan Deng; Zhijie Niu; LiangLiang Fan; Jie Ling; Hongsheng Chen; Xinzhang Cai; Lingyun Mei; Chufeng He; Xuewei Zhang; Jie Wen; Meng Li; Wu Li; Taoxi Li; Shushan Sang; Yalan Liu; Yong Feng
Journal:  J Hum Genet       Date:  2018-03-20       Impact factor: 3.172

2.  Study of complex structural variations of X-linked deafness-2 based on single-molecule sequencing.

Authors:  Yi Jiang; Lihua Wu; Shasha Huang; Pidong Li; Bo Gao; Yongyi Yuan; Siwen Zhang; Guoliang Yu; Yong Gao; Hao Wu; Pu Dai
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

3.  A New Pathogenic Variant in POU3F4 Causing Deafness Due to an Incomplete Partition of the Cochlea Paved the Way for Innovative Surgery.

Authors:  Ahmet M Tekin; Marco Matulic; Wim Wuyts; Masoud Zoka Assadi; Griet Mertens; Vincent van Rompaey; Yongxin Li; Paul van de Heyning; Vedat Topsakal
Journal:  Genes (Basel)       Date:  2021-04-21       Impact factor: 4.096

4.  Research progress of the transcription factor Brn4 (Review).

Authors:  Yuying Wu; Xunrui Zhang; Jue Wang; Guohua Jin; Xinhua Zhang
Journal:  Mol Med Rep       Date:  2021-01-05       Impact factor: 2.952

5.  Position effect, cryptic complexity, and direct gene disruption as disease mechanisms in de novo apparently balanced translocation cases.

Authors:  Constantia Aristidou; Athina Theodosiou; Mads Bak; Mana M Mehrjouy; Efthymia Constantinou; Angelos Alexandrou; Ioannis Papaevripidou; Violetta Christophidou-Anastasiadou; Nicos Skordis; Sophia Kitsiou-Tzeli; Niels Tommerup; Carolina Sismani
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

6.  A novel POU domain class 3 transcription factor 4 mutation causes X-linked non-syndromic hearing loss in a Chinese family.

Authors:  Hong-Min Wu; Hui-Qun Jie; Hui Wang; Ya-Qin Wu; Zheng-Nong Chen; Ya-Zhi Xing; Ji-Ping Wang; Hai-Bo Shi; Shan-Kai Yin
Journal:  Chin Med J (Engl)       Date:  2019-09-20       Impact factor: 2.628

7.  The Cause of Hereditary Hearing Loss in GJB2 Heterozygotes-A Comprehensive Study of the GJB2/DFNB1 Region.

Authors:  Dana Safka Brozkova; Anna Uhrova Meszarosova; Petra Lassuthova; Lukáš Varga; David Staněk; Silvia Borecká; Jana Laštůvková; Vlasta Čejnová; Dagmar Rašková; Filip Lhota; Daniela Gašperíková; Pavel Seeman
Journal:  Genes (Basel)       Date:  2021-05-01       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.